Category Archives: OxSyBio

Carnegie Mellon University researchers publish designs for open-source 3D bioprinter

Researchers at Carnegie Mellon University have developed an open-source, low-cost 3D bioprinter. They have published a paper in HardwareX with the complete instructions for the installation of a syringe-based large volume extruder (LVE) on a desktop FDM 3D printer. The LVE allows users to print artificial human tissues at a high resolution and scale. It […]

Carnegie Mellon University researchers publish designs for open-source 3D bioprinter

Researchers at Carnegie Mellon University have developed an open-source, low-cost 3D bioprinter. They have published a paper in HardwareX with the complete instructions for the installation of a syringe-based large volume extruder (LVE) on a desktop FDM 3D printer. The LVE allows users to print artificial human tissues at a high resolution and scale. It […]

OxSyBio high resolution tissue 3D bioprinting raises £10m in funding

OxSyBio, a 3D bioprinting spinout company of the University of Oxford, has raised £10 million (approx. $14 million USD) in Series A financing. The money, according to company founder and director Professor Hagan Bayley, “provides the long-term capital required to deliver our ambition of building affordable tissues for patients.” Part of Professor Bayley’s vision for the […]

OxSyBio high resolution tissue 3D bioprinting raises £10m in funding

OxSyBio, a 3D bioprinting spinout company of the University of Oxford, has raised £10 million (approx. $14 million USD) in Series A financing. The money, according to company founder and director Professor Hagan Bayley, “provides the long-term capital required to deliver our ambition of building affordable tissues for patients.” Part of Professor Bayley’s vision for the […]

OxSyBio Targets 3D Printing of Synthetic Tissues, Organs

(Medical Xpress) A University of Oxford spin-off, OxSyBio, will develop 3D-printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term, the company aims to print synthetic tissues for organ repair or replacement. Isis Innovation, the University’s research commercialization company, announced Thursday that OxSyBio has raised £1 million from IP Group plc, the developer of intellectual-property-based businesses, subject to the achievement of milestones. The new company will refine and advance the 3D droplet printing technology devised by professor Hagan Bayley’s group at Oxford University’s Department of Chemistry.

Professor Bayley’s group has developed a technique to print synthetic tissue-like materials from thousands of tiny water droplets, each coated in a thin film mimicking a living cell’s external membrane, and studding these membranes with protein pores so they act like simplified cells. The group’s research was featured on the cover page of Science in April 2013.

New Career Opportunities Daily: The best jobs in media.